CVS Health Ventures

Venture capital firm

Recent changes

  1. Jul 30, 2026Invested in Simile (Series B, $200M) TechCrunch

Portfolio

1 total

Recent Investment Activity

1

Track record: led 0 and participated in 1 of 1 tracked venture round · 1 in the last 12 months

DateCompanyEventRoleAmountValuationInvestorsSource
Jul 30, 2026SimileSeries BParticipated$200M$2BTechCrunch

Co-Investors

6

Value Add Research

Latest Pulse

  1. Thyme Care Doubles to $2B on Cancer NavigationMorgan Health led a $125 million Series E with Humana and CVS Health Ventures joining, as the Nashville company's oncology navigation service reached 135,000 actively treated patients.→
  2. Simile Raises $200M to Simulate Human Behavior at ScaleSimile raised a $200 million Series B led by Greenoaks at a $2 billion valuation, just five months after its $100 million Series A, to build foundation models that simulate how humans will respond to products and decisions before they ship.→
  3. Simile Raises $200M at $2B to Simulate Human BehaviorSynthetic-user startup Simile closed a $200 million Series B at a $2 billion valuation, just five months after its $100 million Series A, to scale AI simulations that predict how real people will behave.→

CVS Health Ventures FAQ

What companies has CVS Health Ventures invested in?

CVS Health Ventures' portfolio includes Simile.

Who does CVS Health Ventures co-invest with most?

In the rounds Value Add tracks, CVS Health Ventures most often invests alongside Bain Capital Ventures (1 shared deal), Capital A Partners (1 shared deal), Factory (1 shared deal), Greenoaks (1 shared deal), Hanabi (1 shared deal).

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction